HPV detect by Sephirah Innovations Pvt. Ltd. (India) - No more painful biopsy - Changing oral cancer care with our simple and accurate HPV saliva test
Sephirah Innovations Pvt. Ltd. (India) is pioneering the next generation of diagnostics. They are developing the first comprehensive HPV saliva test, an accurate and simple exosome-based tool for complete oral cancer care, including screening, diagnosis, treatment stratification, and follow-up. The company is recognized for its innovation, holding a granted Indian patent and pending international IP, and has secured vital funding, notably the BIRAC-BIG grant. Accolades include the BIRAC Ignite Cambridge Judge Business School Fellowship, recognition as a Hello Tomorrow Deep Tech Pioneer, and being featured in the BIRAC Coffee Table Book on '75 Women Entrepreneurs'.
Raised Rs 40 lakhs from IIIT Hyderabad (Avishkar Medtech Accelerator Investment) and AIC Banasthali Vidyapith (Nidhi SSS Investment). Received Rs 74 lakhs grant from Apollo Hospitals Educational and Research Foundation, BIRAC BIG Grant, and PRIF (IIIT Hyderabad) Grant.
Non-invasive exosome-based head and neck cancer diagnosis. Status: Indian patent granted, European patent awaiting grant document, US patent under process.
Winner of iHub Equity Free Grant Challenge (2022) and IKP PRIME-IISER Technology Showcase (2023)
Our team consists of 10 members, including a CEO, research assistants, and highly experienced mentors and advisors.
Founder and CEO
Research Assistant
R&D Advisor
Scientific Mentor and Advisor
Advisor and Mentor - Commercialization
